India's Venus Remedies gains after Q3 profit jump
** Shares of Venus Remedies VENR.NS rise 5% to 820.6 rupees, highest in over a month ** Pharma co's Q3 consol net profit rises 30.5% Y/Y, helped by smaller expenses; rev up 2% ** Stock rose 140% in 2025 (Reporting by Aleef Jahan in Bengaluru) ((aleefjahan.cs@thomsonreuters.com))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage